The previous study documented that cytokine-expanded CD33+ MDSC from T1D patients and healthy donors equally suppressed allogeneic T cell proliferation, whereas CD33+ MDSC purified from the blood of T1D patients have diminished suppressive function in vitro in terms of reducing the proliferation of T cells isolated from healthy donors [36]. Here, CD33 is linked to type 1 diabetes mellitus.